Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
national blog main
3
×
national top stories
new york blog main
new york top stories
3
×
startups
wisconsin blog main
3
×
wisconsin top stories
abbvie
alzheimer's disease
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
detroit blog main
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
merck
national
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
adverum biotechnologies
albert bourla
What
biggest
3
×
acquisitions
bio
ceo
drug
roundup
albert
appear
bourla
build
buy
companies
company
company’s
crispr
daniel
deal
debut
deerfield
didn't
dyne’s
end
eyeing
future
gilead
happening
imports
investment
involved
maker
maps
measured
medical
memory
microbiome
moves
openly
o’day
patients
pfizer
Language
unknown
unset
Current search:
biggest
×
" national blog main "
×
" new york top stories "
×
" wisconsin blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield